Published in Tidsskr Nor Laegeforen on October 30, 1990
A comparison of budesonide and mesalamine for active Crohn's disease. International Budesonide-Mesalamine Study Group. N Engl J Med (1998) 2.54
Mucosal changes in the gastric stump 20-25 years after partial gastrectomy. Lancet (1977) 2.41
Intestinal perforation after ingestion of a blister-wrapped tablet. Lancet (1995) 2.22
[Will the shape of children's heads be standardized?]. Tidsskr Nor Laegeforen (1999) 1.92
Effect of near normoglycaemia for two years on progression of early diabetic retinopathy, nephropathy, and neuropathy: the Oslo study. Br Med J (Clin Res Ed) (1986) 1.83
Primary sclerosing cholangitis: a long-term follow-up study. Scand J Gastroenterol (1987) 1.73
Growth of colorectal polyps: recovery and evaluation of unresected polyps of less than 10 mm, 1 year after detection. Scand J Gastroenterol (1994) 1.66
Laparoscopic resection of the pancreas: a feasibility study of the short-term outcome. Surg Endosc (2004) 1.59
HLA antigens and immunoregulatory T cells in ulcerative colitis associated with hepatobiliary disease. Scand J Gastroenterol (1982) 1.53
Liver transplantation in the Nordic countries, 1982-1998: changes of indications and improving results. Scand J Gastroenterol (1999) 1.45
[Follow up after potential curative surgery of colorectal cancer. Guidelines from the Norwegian Gastrointestinal Cancer Group]. Tidsskr Nor Laegeforen (1997) 1.44
Similar effects on infants of n-3 and n-6 fatty acids supplementation to pregnant and lactating women. Pediatrics (2001) 1.43
Deletion of 1p loci and microsatellite instability in colorectal polyps. Genes Chromosomes Cancer (1995) 1.43
Cholangiocarcinoma in primary sclerosing cholangitis: risk factors and clinical presentation. Scand J Gastroenterol (2002) 1.40
[Natural products can be hazardous to health]. Tidsskr Nor Laegeforen (1992) 1.39
HLA class II haplotypes in primary sclerosing cholangitis patients from five European populations. Tissue Antigens (1999) 1.35
Hereditary tyrosinemia type I. Self-induced correction of the fumarylacetoacetase defect. J Clin Invest (1993) 1.32
Vitamin D deficiency, bone mineral density and weight in patients with advanced pulmonary disease. J Intern Med (2004) 1.29
Sclerosing cholangitis in ulcerative colitis. Scand J Gastroenterol (1980) 1.28
Health-related quality of life in patients with inflammatory bowel disease five years after the initial diagnosis. Scand J Gastroenterol (2004) 1.28
A comparative study of the short-term outcome following open and laparoscopic liver resection of colorectal metastases. Surg Endosc (2002) 1.27
Crohn's disease: increased mortality 10 years after diagnosis in a Europe-wide population based cohort. Gut (2005) 1.26
Variations in middle cerebral artery blood flow investigated with noninvasive transcranial blood velocity measurements. Stroke (1988) 1.25
In situ measurement of colorectal polyps to compare video and fiberoptic endoscopes. Endoscopy (1994) 1.21
Digital subtraction angiography (DSA) in the evaluation of brain death. A comparison of conventional cerebral angiography with intravenous and intraarterial DSA. Neuroradiology (1985) 1.16
Relationship of inflammatory bowel disease and primary sclerosing cholangitis. Semin Liver Dis (1991) 1.15
Mucosal proctectomy with straight ileoanal anastomosis. A comparison of two methods. Scand J Gastroenterol (1988) 1.09
Somatosensory conduction times and peripheral, cervical and cortical evoked potentials in patients with cervical spondylosis. J Neurol Neurosurg Psychiatry (1980) 1.08
Patients with small duct primary sclerosing cholangitis have a favourable long term prognosis. Gut (2002) 1.05
Psoriasis induced by interferon-alpha. Br J Dermatol (1991) 1.04
Laparoscopic cholecystectomy: bile duct and vascular injuries: management and outcome. Scand J Gastroenterol (2002) 1.04
Plasma carcinoembryonic antigen concentrations and immunohistochemical patterns of epithelial marker antigens in patients with large bowel carcinoma. J Clin Pathol (1982) 1.03
Role of alimentation in irritable bowel syndrome. Digestion (2003) 1.02
Dysplasia and cancer in inflammatory bowel disease 10 years after diagnosis: results of a population-based European collaborative follow-up study. Digestion (2007) 1.01
Growth and recurrence of colorectal polyps: a double-blind 3-year intervention with calcium and antioxidants. Digestion (1998) 1.00
Effects of social and token reinforcement on WISC block design performance. Percept Mot Skills (1971) 0.98
Epidemiology of polyps in the rectum and sigmoid colon. Evaluation of nutritional factors. Scand J Gastroenterol (1986) 0.97
Primary sclerosing cholangitis is associated with extended HLA-DR3 and HLA-DR6 haplotypes. Tissue Antigens (2007) 0.97
Different HLA class II associations in ulcerative colitis patients with and without primary sclerosing cholangitis. Genes Immun (2007) 0.96
Serum concentration of trimipramine (Surmontil) and gastric secretion of acid and pepsin following peroral administration of the drug in healthy humans. Scand J Gastroenterol (1979) 0.96
The effect of haemodilution on arterial blood pressure, central venous pressure, intracranial and intra-ocular pressures in pigs. Scand J Thorac Cardiovasc Surg (1981) 0.96
Straight ileoanal anastomosis with preserved anal mucosa for ulcerative colitis and familial polyposis. Scand J Gastroenterol (1988) 0.96
Urgent surgery for ulcerative colitis: early colectomy in 132 patients. World J Surg (1981) 0.95
Incidence of malignancies of the Billroth II operated stomach. A prospective follow-up. Scand J Gastroenterol Suppl (1981) 0.95
Ulcerative colitis: no rise in mortality in a European-wide population based cohort 10 years after diagnosis. Gut (2006) 0.95
Features of autoimmune hepatitis in primary sclerosing cholangitis: an evaluation of 114 primary sclerosing cholangitis patients according to a scoring system for the diagnosis of autoimmune hepatitis. Hepatology (1996) 0.94
The in vivo metabolism of C3 in hepatobiliary disease associated with ulcerative colitis. Scand J Gastroenterol (1982) 0.94
Use of anti-tumour necrosis factor agents in inflammatory bowel disease. European guidelines for 2001-2003. Int J Colorectal Dis (2001) 0.94
Surgical treatment as a principle in patients with advanced abdominal carcinoid tumors. Surgery (1992) 0.93
The effect of somatostatin on pentagastrin-stimulated gastric secretion and on plasma gastrin in man. Scand J Gastroenterol (1977) 0.93
Epidemiology of polyps in the rectum and sigmoid colon. Design of a population screening study. Scand J Gastroenterol (1985) 0.93
Cerebral perfusion during nonpulsatile cardiopulmonary bypass. Ann Thorac Surg (1985) 0.92
Liver transplantation in a 23-year-old tyrosinaemia patient: effects on the renal tubular dysfunction. J Inherit Metab Dis (1986) 0.92
An autoantibody profile in primary sclerosing cholangitis. J Hepatol (1987) 0.92
Effect of gastric distention on motility and plasma gastrin concentration before and after secretin administration. Scand J Gastroenterol (1974) 0.92
Metabolic clearance and disappearance rates of synthetic human gastrin in man. Scand J Gastroenterol (1973) 0.92
Epidemiology of ulcerative colitis in western Norway. Scand J Gastroenterol (1988) 0.91
Primary sclerosing cholangitis is associated to an extended B8-DR3 haplotype including particular MICA and MICB alleles. Hepatology (2001) 0.91
A small dose of somatostatin inhibits the pentagastrin stimulated gastric secretion of acid, pepsin and intrinsic factor in man. Clin Endocrinol (Oxf) (1978) 0.91
Sclerosing cholangitis in ulcerative colitis. A follow-up study. Scand J Gastroenterol (1982) 0.91
Hepatic lesions in adult coeliac disease. Scand J Gastroenterol (1990) 0.90
Epidemiology of Crohn's disease in western Norway. Study group of Inflammatory Bowel Disease in Western Norway. Scand J Gastroenterol (1989) 0.90
Intestinal reactivity to words with emotional content and brain information processing in irritable bowel syndrome. Dig Dis Sci (2000) 0.90
The HLA-DR3,DQ2 heterozygous genotype is associated with an accelerated progression of primary sclerosing cholangitis. Scand J Gastroenterol (2001) 0.89
Epidemiology of polyps in the rectum and sigmoid colon. Endoscopic evaluation of size and localization of polyps. Scand J Gastroenterol (1985) 0.89
Cerebral blood flow and evoked potentials during reoxygenation with 21 or 100% O2 in newborn pigs. J Appl Physiol (1985) (1993) 0.89
Association analysis of MYO9B gene polymorphisms and inflammatory bowel disease in a Norwegian cohort. Tissue Antigens (2006) 0.89
Outcome following liver transplantation for primary sclerosing cholangitis in the Nordic countries. Scand J Gastroenterol (2003) 0.89
Cholangiocarcinoma in primary sclerosing cholangitis: K-ras mutations and Tp53 dysfunction are implicated in the neoplastic development. J Hepatol (2000) 0.89
Reliability of in situ measurements of colorectal polyps. Scand J Gastroenterol (1992) 0.88
Hepatobiliary disease in ulcerative colitis. An analysis of 18 patients with hepatobiliary lesions classified as small-duct primary sclerosing cholangitis. Scand J Gastroenterol (1994) 0.88
Changes in intracranial pressure after calvarial expansion surgery in children with slit ventricle syndrome. Pediatr Neurosurg (2001) 0.87
Growth rate of colon polyps and cancer. Gastrointest Endosc Clin N Am (1997) 0.87
Head injuries during one year in a central hospital in Norway: a prospective study. Epidemiologic features. Neuroepidemiology (1988) 0.87
Vitamin B 12 in the serum and the cerebrospinal fluid. Acta Neurol Scand (1970) 0.87
The effect of gastric bypass operation on glucose tolerance in obesity. Scand J Gastroenterol Suppl (1985) 0.86
Enzyme activities in the gastric mucosa in duodenal ulcer patients. Scand J Gastroenterol (1990) 0.86
The metabolic clearance rate and half-life of synthetic human gastrin in dogs. Scand J Gastroenterol (1973) 0.86
Two generators of hippocampal theta activity in rabbits. Brain Res (1975) 0.86
Is a prolonged bleeding time associated with an increased risk of hemorrhage after liver biopsy? Thromb Haemost (1999) 0.85
Neurosurgical treatment of meningiomas in children and young adults. Childs Nerv Syst (2001) 0.85
Cytokines, bone turnover markers and weight change in candidates for lung transplantation. Pulm Pharmacol Ther (2007) 0.85
Gastrin secretion before and after gastric bypass surgery for morbid obesity. Scand J Gastroenterol (1981) 0.85
Validation of a self-administered form for recording food intake in hospital patients. Eur J Clin Nutr (1998) 0.85
Complete biliocolic fistula. Scand J Gastroenterol (1975) 0.85
Growth of colorectal polyps: design of a prospective, randomized, placebo-controlled intervention study in patients with colorectal polyps. Eur J Cancer Prev (1992) 0.85
Failed ileoanal anastomosis: correlations between clinical function and anal canal neurophysiologic and histologic examinations. Scand J Gastroenterol (1989) 0.84
The effect of carbachol and pentagastrin on the gastric secretion of acid pepsin, and intrinsic factor (IF) in man. Scand J Gastroenterol (1975) 0.84
EEG and evoked potentials in comatose patients with severe brain damage. Electroencephalogr Clin Neurophysiol (1988) 0.84
The 32-base pair deletion of the chemokine receptor 5 gene (CCR5-Delta32) is not associated with primary sclerosing cholangitis in 363 Scandinavian patients. Tissue Antigens (2006) 0.84
Mesalazine (Mesasal/Claversal) 1.5 g b.d. vs. placebo in the maintenance of remission of patients with Crohn's disease. Aliment Pharmacol Ther (1995) 0.84
Posterior fossa medulloblastoma in children and young adults (0-19 years): survival and performance. Childs Nerv Syst (1999) 0.84
Serum gastrin and gastric acid secretion before and after proximal gastric vagotomy. Scand J Gastroenterol (1974) 0.84
Treatment of malignant metastatic midgut carcinoid tumours with recombinant human alpha2b interferon with or without prior hepatic artery embolization. Scand J Gastroenterol (1989) 0.84